Predictive models for one-year renal function improvement in patients with atherosclerotic renal artery stenosis (ARAS) following renal artery revascularization: a real-world study from China

肾动脉血运重建术后动脉粥样硬化性肾动脉狭窄(ARAS)患者一年肾功能改善的预测模型:一项来自中国的真实世界研究

阅读:1

Abstract

The efficacy of interventional treatment for atherosclerotic renal artery stenosis (ARAS) in improving renal function remains controversial. The aim of this study was to develop a predictive model for estimating the probability of renal function response within one year following renal artery intervention in patients with ARAS. We retrospectively analyzed ARAS patients with renal artery intervention from January 2020 to December 2024 at Peking University First Hospital consecutively. Candidate predictors were selected using least absolute shrinkage and selection operator (LASSO) regression. A multivariable logistic regression model and a support vector machine (SVM) model were developed and internally validated using nested cross-validation. Discrimination was assessed by the area under the precision-recall curve (AUPRC), and calibration by the Brier score. 224 cases were enrolled, among which 47 patients exhibited renal function response following interventional treatment. LASSO regression identified four predictors (age, baseline renal function, diabetes, and bilateral renal artery stenosis) for model development. According to the results of internal validation, the mean AUPRC of logistic regression model was 0.701 (95% CI: 0.580, 0.834) and SVM model was 0.753 (95% CI: 0.642, 0.864). The logistic regression model demonstrated a mean Brier score of 0.150 (95% CI: 0.118, 0.182), whereas the SVM model with a mean Brier score of 0.148 (95% CI: 0.105, 0.193), indicating good calibration and stable performance. After further external validation, the models may serve as a risk stratification and post-procedural prognostic counseling aid for both patients and physicians.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。